IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC
© European Society for Medical Oncology 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Chemotherapy remains the mainstay therapy for metastatic triple-negat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 December 2016
|
| In: |
Annals of oncology
Year: 2016, Volume: 27 |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/S0923-7534(21)00294-5 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/S0923-7534(21)00294-5 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753421002945 
|
| Author Notes: | L. Emens, S. Adams, S. Loi, A. Schneeweiss, H. Rugo, E. Winer, C. Barrios, V. Dieras, J. de la Haba-Rodriguez, L. Gianni, N. Kusuma, S.Y. Chui, P. Schmid |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1563389622 | ||
| 003 | DE-627 | ||
| 005 | 20240927095509.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170911s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdw577.019 |2 doi | |
| 035 | |a (DE-627)1563389622 | ||
| 035 | |a (DE-576)493389628 | ||
| 035 | |a (DE-599)BSZ493389628 | ||
| 035 | |a (OCoLC)1340979231 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Emens, Leisha Ann |e VerfasserIn |0 (DE-588)1139674196 |0 (DE-627)897410122 |0 (DE-576)493389598 |4 aut | |
| 245 | 1 | 0 | |a IMpassion130 |b Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC |c L. Emens, S. Adams, S. Loi, A. Schneeweiss, H. Rugo, E. Winer, C. Barrios, V. Dieras, J. de la Haba-Rodriguez, L. Gianni, N. Kusuma, S.Y. Chui, P. Schmid |
| 264 | 1 | |c 20 December 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.09.2017 | ||
| 520 | |a © European Society for Medical Oncology 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Chemotherapy remains the mainstay therapy for metastatic triple-negative breast cancer (mTNBC) but offers limited clinical benefit at the expense of significant toxicity. This underscores the need for new treatment options. Atezolizumab (atezo) is a mAb specific for PD-L1 that prevents PD-L1 binding to its receptors PD-1 and B7.1, thereby restoring tumor-specific T-cell immunity. TNBC is a rational target indication for atezo due to PD-L1 expression on tumor-infiltrating immune cells (IC), and a high mutation burden that may generate immunogenic neoantigens. Atezo monotherapy was well tolerated and produced durable responses in patients (pts) with mTNBC (Emens et al 2015). Promising activity observed in pts treated with atezo plus nab-paclitaxel (nab-pac) supports the hypothesis that the combination may represent an effective new... | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 27(2016,Supplement 9) Artikel-Nummer 136TiP, 1 Seite |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a IMpassion130 Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC |
| 773 | 1 | 8 | |g volume:27 |g year:2016 |g supplement:Supplement 9 |a IMpassion130 Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0923-7534(21)00294-5 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0923753421002945 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170911 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |e 910000PS109972554 |k 0/910000/ |p 4 | ||
| 999 | |a KXP-PPN1563389622 |e 2980009407 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"20 December 2016","dateIssuedKey":"2016"}],"relHost":[{"disp":"IMpassion130 Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBCAnnals of oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"language":["eng"],"part":{"year":"2016","volume":"27","text":"27(2016,Supplement 9) Artikel-Nummer 136TiP, 1 Seite"},"pubHistory":["1.1990 -"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"title":[{"title_sort":"Annals of oncology","title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"origin":[{"dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990"}],"recId":"320428796"}],"id":{"doi":["10.1093/annonc/mdw577.019"],"eki":["1563389622"]},"title":[{"title_sort":"IMpassion130","title":"IMpassion130","subtitle":"Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 11.09.2017"],"recId":"1563389622","person":[{"given":"Leisha Ann","display":"Emens, Leisha Ann","family":"Emens","role":"aut"},{"family":"Schneeweiss","role":"aut","given":"Andreas","display":"Schneeweiss, Andreas"}],"name":{"displayForm":["L. Emens, S. Adams, S. Loi, A. Schneeweiss, H. Rugo, E. Winer, C. Barrios, V. Dieras, J. de la Haba-Rodriguez, L. Gianni, N. Kusuma, S.Y. Chui, P. Schmid"]},"language":["eng"]} | ||
| SRT | |a EMENSLEISHIMPASSION12020 | ||